Vienna Medtech Startup Turn-Motion Secures Seed Investment

Vienna-based Turn-Motion, a promising player in the orthotics and medical technology space, has successfully attracted its initial institutional investment. The funding round, which marks a significant milestone for the young company, saw participation from prominent venture capital firm Noctua Science Ventures. This infusion of capital is expected to accelerate Turn-Motion's product development and market expansion within the rapidly growing healthtech sector.

The investment from Noctua Science Ventures underscores the potential perceived in Turn-Motion's innovative approach to orthotic solutions. While the specific financial terms of the deal remain undisclosed, the involvement of a respected VC like Noctua signals strong confidence in the startup's technology and business strategy. The broader medical device market, particularly in areas like personalized orthotics and rehabilitation technology, is experiencing robust growth, driven by an aging global population and increasing demand for non-invasive treatment options.

Beyond the lead investor, Turn-Motion also welcomed strategic backing from Squer, a successful Viennese tech scale-up. This collaboration suggests potential synergies and operational expertise that could significantly benefit Turn-Motion's growth trajectory. Furthermore, the round included investments from a group of experienced business angels: Florian Schwendinger, Benjamin Schwendinger, and Sébastien Stassin. Their collective experience in scaling technology ventures is anticipated to provide invaluable guidance and network access.

Turn-Motion operates within the intersection of healthcare, healthtech, and advanced software solutions. The company aims to revolutionize the creation and application of orthotic devices, potentially leveraging digital technologies for enhanced customization and patient outcomes. The global orthotics and prosthetics market is projected to reach tens of billions of dollars in the coming years, with significant opportunities for companies offering disruptive technologies and improved patient care pathways.

This early-stage funding positions Turn-Motion to further refine its offerings and capture market share. The company's focus on innovation in a critical healthcare segment aligns with current investment trends favoring technologies that address unmet medical needs and improve quality of life. The successful closure of this round provides a solid foundation for future growth and potential Series A funding as the company scales its operations and commercializes its products.

The strategic alignment with Noctua Science Ventures and Squer, coupled with the support of seasoned business angels, provides Turn-Motion with a powerful combination of financial resources and industry acumen. This backing is crucial for navigating the complex regulatory environment and competitive dynamics inherent in the medtech industry, paving the way for significant advancements in patient-specific orthotic care.